Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Non-Current Deferred Tax Liability (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Non-Current Deferred Tax Liability for 10 consecutive years, with $490690.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Deferred Tax Liability fell 37.05% year-over-year to $490690.0, compared with a TTM value of $490690.0 through Sep 2025, down 37.05%, and an annual FY2024 reading of $490690.0, down 37.05% over the prior year.
  • Non-Current Deferred Tax Liability was $490690.0 for Q3 2025 at Kiora Pharmaceuticals, roughly flat from $490690.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $802131.0 in Q4 2021 and bottomed at $490690.0 in Q4 2024.
  • Average Non-Current Deferred Tax Liability over 5 years is $696843.6, with a median of $728926.0 recorded in 2021.
  • The sharpest move saw Non-Current Deferred Tax Liability soared 99.51% in 2021, then plummeted 37.05% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $802131.0 in 2021, then changed by 0.0% to $802131.0 in 2022, then decreased by 2.83% to $779440.0 in 2023, then tumbled by 37.05% to $490690.0 in 2024, then changed by 0.0% to $490690.0 in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for KPRX at $490690.0 in Q3 2025, $490690.0 in Q2 2025, and $490690.0 in Q1 2025.